相关实验视频
Updated: Jul 17, 2025

12:39
Implantation of Inferior Vena Cava Interposition Graft in Mouse Model
Published on: June 4, 2014
12.0K
直接口服抗凝剂用于下静脉卡瓦瓦 Agenesis
Michael Iarossi1, Cedric Hermans1
1Division of Haematology, Haemostasis and Thrombosis Unit, Saint-Luc University Hospital, Université catholique de Louvain (UCLouvain), Brussels, Belgium.
概括
下静脉干发育 (IVCA) 是一种罕见的疾病,增加了深静脉血栓形成 (DVT) 的风险. 在患有IVCA的DVT患者中,直接口服抗凝剂的延长治疗显示出良好的疗效和安全性.
科学领域:
- 血管医学 血管医学
- 血液学 血液学 血液学
- 胚胎学 胚胎学
背景情况:
- 深静脉血栓症 (DVT) 每年影响1000人中的1-2人.
- 低静脉发症 (IVCA) 是一种罕见的先天性异常,显著增加了DVT的风险,特别是在年轻人中.
- 目前对IVCA患者延长DVT治疗的管理指南有限.
研究的目的:
- 评估直接口服抗凝剂 (DOACs) 的有效性和安全性,用于在患有DVT和IVCA的患者中延长治疗.
- 为管理这一高风险患者群体提供见解.
主要方法:
- 对11名在DVT后被诊断患有IVCA的患者进行了回顾性队列研究.
- 患者接受了使用DOACs的延长抗凝治疗.
主要成果:
- 在患有DVT和IVCA的患者中,DOACs表现出有效的抗血栓作用.
- 在长时间使用过程中,该疗法表现出良好的安全性.
- 结果表明,DOACs是这种人群的长期管理的可行选择.
结论:
- 对于患有与IVCA相关的DVT的患者,使用DOAC的延长治疗似乎是安全和有效的.
- 进一步的研究是有必要的,以建立标准化的治疗方案.
相关概念视频
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
749
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
749
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
14
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
14
Hemodialysis I: Introduction
54
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
54
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10

